BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/25/2021 6:50:38 AM | Browse: 13 | Download: 20
Publication Name World Journal of Cardiology
Manuscript ID 66137
Country/Territory Croatia
Received
2021-03-23 20:21
Peer-Review Started
2021-03-23 20:23
To Make the First Decision
Return for Revision
2021-07-30 04:59
Revised
2021-08-06 08:43
Second Decision
2021-10-22 06:45
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-10-25 02:08
Articles in Press
2021-10-25 02:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-11-23 12:34
Publish the Manuscript Online
2021-11-25 06:50
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Opinion Review
Article Title Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease
Manuscript Source Invited Manuscript
All Author List Zvonimir Ostojic, Ana Ostojic, Josko Bulum and Anna Mrzljak
ORCID
Author(s) ORCID Number
Zvonimir Ostojic http://orcid.org/0000 0003 1762 9270
Ana Ostojic http://orcid.org/0000-0003-4234-4461
Josko Bulum http://orcid.org/0000 0002 1482 6503
Anna Mrzljak http://orcid.org/0000-0001-6270-2305
Funding Agency and Grant Number
Corresponding Author Ana Ostojic, MD, PhD, Senior Postdoctoral Fellow, Department of Gastroenterology and Hepatology, University Hospital Center, Kispaticeva 12, Zagreb 10000, Croatia. ostojicana.zg@gmail.com
Key Words End-stage liver disease; Cirrhosis; Liver transplantation; Coronary artery disease; Percutaneous coronary intervention; Antiplatelet therapy
Core Tip Dual antiplatelet therapy (DAPT) is necessary after a percutaneous coronary intervention (PCI). However, it could result in severe consequences in patients with liver cirrhosis. Based on novel findings, liver cirrhosis does not necessarily lead to a significant increase in bleeding complications. Patients with cirrhosis who have the highest bleeding risk are those with severe thrombocytopenia and elevated portal pressure. Despite the lack of solid evidence for DAPT in patients with cirrhosis, trials investigating one month of DAPT duration after PCI can be implemented in cirrhotic patients. Before PCI, functional assessment of coronary artery disease severity should be performed to avoid unnecessary interventions.
Publish Date 2021-11-25 06:50
Citation Ostojic Z, Ostojic A, Bulum J, Mrzljak A. Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease. World J Cardiol 2021; 13(11): 599-607
URL https://www.wjgnet.com/1949-8462/full/v13/i11/599.htm
DOI https://dx.doi.org/10.4330/wjc.v13.i11.599
Full Article (PDF) WJC-13-599.pdf
Full Article (Word) WJC-13-599.docx
Manuscript File 66137_Auto_Edited.docx
Answering Reviewers 66137-Answering reviewers.pdf
Audio Core Tip 66137-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 66137-Conflict-of-interest statement.pdf
Copyright License Agreement 66137-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 66137-Language certificate.pdf
Peer-review Report 66137-Peer-review(s).pdf
Scientific Editor Work List 66137-Scientific editor work list.pdf